Sphera Funds Management’s Epizyme, Inc EPZM Stock Holding History

Sphera Funds Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-749,502	Closed	-$4.62M	–	128
2018 Q4	$4.62M	Buy	749,502 +350,000	+88%	+$2.67M	0.52%	44
2018 Q3	$4.24M	Buy	399,502 +92,348	+30%	+$1.05M	0.49%	59
2018 Q2	$4.16M	Buy	+307,154	New	+$4.78M	0.57%	52
2015 Q4	–	Sell	-150,000	Closed	-$1.93M	–	141
2015 Q3	$1.93M	Buy	+150,000	New	+$3.03M	0.25%	96
2015 Q2	–	Sell	-150,000	Closed	-$2.82M	–	166
2015 Q1	$2.82M	Buy	+150,000	New	+$3.1M	0.29%	86
2014 Q4	–	Sell	-50,000	Closed	-$1.36M	–	155
2014 Q3	$1.36M	Sell	50,000 -63,188	-56%	-$1.96M	0.17%	104
2014 Q2	$3.52M	Buy	+113,188	New	+$2.67M	0.87%	32

Other funds holding EPZM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Sphera Funds Management's EPZM Position: Q1 2019 in Review

Sphera Funds Management sold out of Epizyme, Inc (EPZM) in Q1 2019, closing a stake of 749,502 shares — an estimated $4.62M sold.

Sphera Funds Management first reported a position in EPZM in Q2 2014 and held it in 7 quarters. The position peaked at $4.62M in Q4 2018. 121 funds tracked by Wall St. Rank hold EPZM as of Q1 2019.

Sphera Funds Management reported no remaining Epizyme, Inc position as of Q1 2019 after selling out during the quarter.
Sphera Funds Management sold 749,502 Epizyme, Inc shares in Q1 2019, an estimated $4.62M.
Sphera Funds Management first reported a position in Epizyme, Inc in Q2 2014 and held it in 7 quarters.
Sphera Funds Management's Epizyme, Inc position peaked at $4.62M in Q4 2018.
121 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.